LEADER 04317nam  22007695  450 
001 9910910497803321
005 20241127115237.0
010   $a9789819746125
010   $a9819746124
024 7 $a10.1007/978-981-97-4612-5
035   $a(CKB)36679664100041
035   $a(MiAaPQ)EBC31806124
035   $a(Au-PeEL)EBL31806124
035   $a(DE-He213)978-981-97-4612-5
035   $a(OCoLC)1474240851
035   $a(EXLCZ)9936679664100041
100   $a20241127d2024      u|         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aProstate Cancer: Molecular Events and Therapeutic Modalities /$fedited by Gautam Sethi, Milad Ashrafizadeh, Nasim Ebrahimi
205   $a1st ed. 2024.
210  1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2024.
215   $a1 online resource (290 pages)
311 08$a9789819746118 
311 08$a9819746116 
327   $aChapter 1. Anatomy and function of prostate -- Chapter 2. Epidemiology, risk factors and histopathological profile of prostate cancer -- Chapter 3. Prostate cancer and Inflammation -- Chapter 4. Prostate cancer, apoptosis, autophagy and ferroptosis: Cell death mechanisms and their crosstalk -- Chapter 5. Prostate cancer and metastasis: An emphasis on EMT mechanism -- Chapter 6. Prostate cancer and Wnt/STAT3 signaling -- Chapter 7. Prostate cancer and EZH2 signaling -- Chapter 8. Prostate cancer and PTEN/PI3K/Akt/mTOR signaling -- Chapter 9. Prostate cancer and non-coding RNAs: A focus on miRNAs, lncRNAs and circRNAs -- Chapter 10. Prostate cancer and tumor microenvironment -- Chapter 11. Chemoresistance, radioresistance and androgen-deprivation therapy resistance in prostate cancer -- Chapter 12. Plant derived-natural products in treatment of prostate cancer -- Chapter 13. Gene therapy as a new emerging strategy for prostate cancer -- Chapter 14. Nanoparticle-based therapeutic strategies in prostate cancer suppression.
330   $aThe book covers the various cell signaling pathways responsible for prostate cancer progression, conventional therapies used for prostate cancer treatment, new emerging therapeutics, and challenges in the treatment of cancer patients. It describes the different molecular pathways responsible for prostate cancer progression to improve readers' knowledge about the role of signaling networks, and cellular and molecular aspects of prostate cancer progression. These topics include mechanisms responsible for prostate cancer malignancy with a focus on molecular pathways. It also discusses the current challenges in prostate cancer treatment such as drug resistance and immune evasion and introduces novel therapeutics such as gene therapy and nanotherapeutics for prostate cancer. This book is completely novel and unique and covers all aspects of prostate cancer progression and challenges in therapy while presenting solutions. Written by prestigious researchers around the world, this book will be interesting to researchers and practitioners, especially those working in urological cancers.
606   $aCancer$xTreatment
606   $aMedical genetics
606   $aCancer
606   $aNanomedicine
606   $aOncology
606   $aEpidemiology
606   $aGenetics$xResearch
606   $aCancer Therapy
606   $aClinical Genetics
606   $aCancer Nanotechnology
606   $aOncology
606   $aEpidemiology
606   $aGenetics Research
615  0$aCancer$xTreatment.
615  0$aMedical genetics.
615  0$aCancer.
615  0$aNanomedicine.
615  0$aOncology.
615  0$aEpidemiology.
615  0$aGenetics$xResearch.
615 14$aCancer Therapy.
615 24$aClinical Genetics.
615 24$aCancer Nanotechnology.
615 24$aOncology.
615 24$aEpidemiology.
615 24$aGenetics Research.
676   $a616.9946306
700   $aSethi$b Gautam$01777044
701   $aAshrafizadeh$b Milad$01777045
701   $aEbrahimi$b Nasim$01777046
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910910497803321
996   $aProstate Cancer: Molecular Events and Therapeutic Modalities$94296450
997   $aUNINA